| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 193.54B | 192.69B | 187.72B | 176.17B | 154.92B | 143.17B |
| Gross Profit | 81.62B | 77.89B | 74.05B | 66.80B | 56.77B | 45.30B |
| EBITDA | 25.63B | 25.65B | 23.58B | 19.47B | 14.62B | 3.59B |
| Net Income | 9.26B | 9.57B | 7.58B | 5.63B | 2.56B | -11.93B |
Balance Sheet | ||||||
| Total Assets | 215.68B | 232.98B | 236.33B | 233.42B | 234.22B | 238.48B |
| Cash, Cash Equivalents and Short-Term Investments | 23.88B | 34.88B | 35.66B | 38.30B | 37.94B | 29.94B |
| Total Debt | 29.71B | 40.66B | 48.22B | 52.70B | 61.97B | 69.68B |
| Total Liabilities | 77.33B | 90.83B | 99.27B | 101.16B | 106.58B | 112.63B |
| Stockholders Equity | 138.05B | 141.84B | 136.76B | 131.97B | 127.64B | 125.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.76B | 6.41B | 12.91B | 9.61B | -5.92B |
| Operating Cash Flow | 0.00 | 21.74B | 17.59B | 17.48B | 17.13B | 4.35B |
| Investing Cash Flow | 0.00 | -8.52B | -10.89B | -3.03B | 886.00M | -11.52B |
| Financing Cash Flow | 0.00 | -13.99B | -9.34B | -14.09B | -10.02B | 13.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥19.61T | 29.11 | 19.84% | 0.90% | 9.56% | 16.37% | |
72 Outperform | ¥71.75B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
72 Outperform | ¥140.54B | 20.46 | ― | 4.49% | 2.21% | 4.36% | |
71 Outperform | ¥124.20B | 24.22 | 5.53% | 6.09% | -1.03% | 4.12% | |
70 Outperform | ¥263.70B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
68 Neutral | ¥758.45B | 16.45 | 8.48% | 2.02% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |